Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
55.18 USD | +1.91% |
|
+14.21% | +54.82% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.82% | 4.27B | |
+25.43% | 46.56B | |
+45.38% | 41.67B | |
-0.07% | 41.16B | |
+33.45% | 32.4B | |
+20.72% | 28.18B | |
-6.35% | 28.1B | |
+48.51% | 14.52B | |
+47.69% | 13.74B | |
+3.50% | 12.17B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- JPMorgan Raises Price Target on Crinetics Pharmaceuticals to $54 From $47, Maintains Overweight Rating